pharma · Achondroplasia · Amyloid Cardiomyopathy, Transthyretin-Related · BBOT
BridgeBio Oncology Therapeutics
News and analysis for BridgeBio Oncology Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
256 E Grand Ave, Suite 104, South San Francisco, California 94080, US HQ
103 Employees
Public company Type
BBOT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 256 E Grand Ave, Suite 104, South San Francisco, California 94080, US
- Employees
- 103
- Programs
- 34
- Drugs
- 14
- Patents
- 1
News & analysis
NovaPharmaNews articles mentioning BridgeBio Oncology Therapeutics — regulatory, clinical, and market coverage.
News and analysis for BridgeBio Oncology Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.